While this isn't typically harmful, it may indicate an underlying condition or excessive supplementation
The pooled safety population received an initial dose of DUPIXENT 600 mg or 400 mg, followed by DUPIXENT 300 mg or 200 mg, respectively, or matching placebo, administered subcutaneously every 2 weeks (Q2W) [see Dosage and Administration (2.9)]
These communications cover risks involving dosing errors, storage and temperature handling, adverse events, and misleading marketing claims that may imply equivalence with FDA-approved finished drugs
Research citations current as of June 2026
The H stands for hyperplasia, a condition in which the cells of an organ reproduce more than normal cells that are present and the organ gets larger
Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody